BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15378038)

  • 1. DNA-microarray analysis of brain cancer: molecular classification for therapy.
    Mischel PS; Cloughesy TF; Nelson SF
    Nat Rev Neurosci; 2004 Oct; 5(10):782-92. PubMed ID: 15378038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliomas: advances in molecular analysis and characterization.
    Boudreau CR; Yang I; Liau LM
    Surg Neurol; 2005 Oct; 64(4):286-94; discussion 294. PubMed ID: 16229087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of pediatric brain tumors: insight into biology and treatment.
    Johnson R; Wright KD; Gilbertson RJ
    Curr Oncol Rep; 2009 Jan; 11(1):68-72. PubMed ID: 19080744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy.
    Vitucci M; Hayes DN; Miller CR
    Br J Cancer; 2011 Feb; 104(4):545-53. PubMed ID: 21119666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
    Persson O; Krogh M; Saal LH; Englund E; Liu J; Parsons R; Mandahl N; Borg A; Widegren B; Salford LG
    J Neurooncol; 2007 Oct; 85(1):11-24. PubMed ID: 17634744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classification of gliomas. Current progress and perspectives].
    Capper D; Reifenberger G
    Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years.
    Northcott PA; Rutka JT; Taylor MD
    Neurosurg Focus; 2010 Jan; 28(1):E6. PubMed ID: 20043721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal patterns of gene expression from microarray data: methodology, validation and clinical relevance in gliomas.
    Turkheimer FE; Roncaroli F; Hennuy B; Herens C; Nguyen M; Martin D; Evrard A; Bours V; Boniver J; Deprez M
    BMC Bioinformatics; 2006 Dec; 7():526. PubMed ID: 17140431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress on molecular biomarkers and classification of malignant gliomas.
    Zhang C; Bao Z; Zhang W; Jiang T
    Front Med; 2013 Jun; 7(2):150-6. PubMed ID: 23681890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets.
    Fuller GN; Hess KR; Rhee CH; Yung WK; Sawaya RA; Bruner JM; Zhang W
    Brain Pathol; 2002 Jan; 12(1):108-16. PubMed ID: 11771519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult medulloblastoma comprises three major molecular variants.
    Remke M; Hielscher T; Northcott PA; Witt H; Ryzhova M; Wittmann A; Benner A; von Deimling A; Scheurlen W; Perry A; Croul S; Kulozik AE; Lichter P; Taylor MD; Pfister SM; Korshunov A
    J Clin Oncol; 2011 Jul; 29(19):2717-23. PubMed ID: 21632505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary brain tumours in adults.
    Lapointe S; Perry A; Butowski NA
    Lancet; 2018 Aug; 392(10145):432-446. PubMed ID: 30060998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of pediatric brain tumors.
    Biegel JA; Pollack IF
    Curr Oncol Rep; 2004 Nov; 6(6):445-52. PubMed ID: 15485613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization of commonly used glioma cell lines in the rat animal model system.
    Sibenaller ZA; Etame AB; Ali MM; Barua M; Braun TA; Casavant TL; Ryken TC
    Neurosurg Focus; 2005 Oct; 19(4):E1. PubMed ID: 16241103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
    Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
    J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data.
    Petalidis LP; Oulas A; Backlund M; Wayland MT; Liu L; Plant K; Happerfield L; Freeman TC; Poirazi P; Collins VP
    Mol Cancer Ther; 2008 May; 7(5):1013-24. PubMed ID: 18445660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and their clinical implication of 89-gene signature in glioma.
    Shahid M; Cho KM; Nguyen MN; Choi TG; Jo YH; Aryal SN; Yoo JY; Yun HR; Lee JW; Eun YG; Lee JS; Kang I; Ha J; Yoon HJ; Kim SY; Kim SS
    Oncotarget; 2016 Aug; 7(32):51237-51250. PubMed ID: 27323413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Brain Tumors: An Update.
    Segal D; Karajannis MA
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):242-250. PubMed ID: 27230809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor prognostic factors and the challenge of developing predictive factors.
    Holliday EB; Sulman EP
    Curr Oncol Rep; 2013 Feb; 15(1):33-46. PubMed ID: 23224629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.